It is also fatal if not administered correctly," Asrat Hailu, professor of immunoparasitology at the University of Addis Ababa in Ethiopia said in an interview with IPS.
The drug has to be administered for a minimum of 30 days in a hospital setting.
"You can imagine what it means in terms of cost.
Again, the process has to be done by a highly skilled medical personnel, and you know how health facilities particularly in the villages are ill-equipped," added Hailu, who is also an official of the Leishmaniasis East Africa Platform.
The network serves seven countries including Kenya, Uganda
, Sudan, Ethiopia, Eritrea, Somalia and Djibouti, and attends to about 30,000 cases every year, half of these coming from Sudan.
was one of the 250 researchers and scientists from 24 countries worldwide who were present at the Nairobi event to review limitations of available treatments for NTDs like in the case of leishmaniasis.